Surmodics receives FDA clearance for its thrombectomy system [Seeking Alpha]
Surmodics, Inc. (SRDX)
Last surmodics, inc. earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
surmodics.gcs-web.com/investor-overview
Company Research
Source: Seeking Alpha
The Pounce XL Thrombectomy System is designed to remove blood clots from peripheral arteries 5.5–10 mm in diameter, such as the iliac and femoral arteries. Surmodics expects to initiate limited market release for the Pounce XL Thrombectomy System in the first half of 2025, with commercialization planned following the completion of the limited market release. Source: Press Release More on Surmodics Surmodics merger deal draws FTC second request Surmodics beats top-line and bottom-line estimates; suspends annual guidance Seeking Alpha's Quant Rating on Surmodics Historical earnings data for Surmodics Financial information for Surmodics Recommended For You Comments More Trending News Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
SRDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRDX alerts
High impacting Surmodics, Inc. news events
Weekly update
A roundup of the hottest topics
SRDX
News
- Surmodics, Inc. (NASDAQ: SRDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- SurModics (SRDX) is an Incredible Growth Stock: 3 Reasons Why [Yahoo! Finance]Yahoo! Finance
- Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down [Yahoo! Finance]Yahoo! Finance
- Surmodics, Inc. (NASDAQ: SRDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Surmodics, Inc. (NASDAQ: SRDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
SRDX
Earnings
- 5/1/24 - Beat
SRDX
Sec Filings
- 11/15/24 - Form SCHEDULE
- 11/14/24 - Form SC
- 11/6/24 - Form SC
- SRDX's page on the SEC website